DIA
MED icon

Dean Investment Associates’s Medifast MED Stock Holding History

Dean Investment Associates’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-30,228
Closed -$2.79M – 212
2023
Q2 		$2.79M Buy
30,228
+1,252
+4% +$111K 0.45% 83
2023
Q1 		$3M Buy
28,976
+21,368
+281% +$2.37M 0.48% 84
2022
Q4 		$878K Buy
+7,608
New +$886K 0.15% 189
2017
Q3 		– Sell
-102,995
Closed -$4.27M – 210
2017
Q2 		$4.27M Buy
102,995
+12,865
+14% +$559K 0.65% 73
2017
Q1 		$4M Buy
90,130
+7,135
+9% +$307K 0.67% 73
2016
Q4 		$3.46M Buy
82,995
+2,160
+3% +$87K 0.59% 83
2016
Q3 		$3.06M Buy
80,835
+72,693
+893% +$2.61M 0.57% 85
2016
Q2 		$271K Buy
+8,142
New +$263K 0.05% 197

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dean Investment Associates's MED Position: Q3 2023 in Review

Dean Investment Associates sold out of Medifast (MED) in Q3 2023, closing a stake of 30,228 shares — an estimated $2.79M sold.

Dean Investment Associates first reported a position in MED in Q2 2016 and held it in 8 quarters. The position peaked at $4.27M in Q2 2017. 223 funds tracked by Wall St. Rank hold MED as of Q3 2023.

  • Dean Investment Associates reported no remaining Medifast position as of Q3 2023 after selling out during the quarter.
  • Dean Investment Associates sold 30,228 Medifast shares in Q3 2023, an estimated $2.79M.
  • Dean Investment Associates first reported a position in Medifast in Q2 2016 and held it in 8 quarters.
  • Dean Investment Associates's Medifast position peaked at $4.27M in Q2 2017.
  • 223 funds tracked by Wall St. Rank held Medifast as of Q3 2023.

Based on Dean Investment Associates's 13F filing for Q3 2023, filed 13 Nov 2023.